TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 12nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 29nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 56nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 72nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 130nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 150nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 160nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 200nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 240nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 240nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 270nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 330nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 620nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 760nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 840nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.10E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.30E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.40E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.40E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.50E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.50E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 2.20E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 3.40E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 3.80E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 4.40E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 5.50E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.30E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.50E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.60E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.80E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.80E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.80E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.80E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.80E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.80E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 2.10E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha [169-468](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 2.20E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair